| Literature DB >> 29234389 |
Lanlan Shan1, Yuanyuan Wu1, Lei Yuan1, Yani Zhang1, Yanyan Xu1, Yubo Li1.
Abstract
Rhizoma Anemarrhenae, a famous traditional Chinese medicine (TCM), is tEntities:
Year: 2017 PMID: 29234389 PMCID: PMC5632855 DOI: 10.1155/2017/4032820
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Characteristic fragments and neutral loss information of chemical substances in the Rhizoma Anemarrhenae.
| Compound classification | Subclass | Characteristic fragments | Neutral loss |
|---|---|---|---|
| Steroidal saponins | |||
| Spirostanol saponins | Type I saponins | 273 [C19H29O]−, 255 [C19H27]−, 301 [C21H33O]−, 283 [C21H31]− | 162 (C6H10O5), 132 (C5H8O4) |
| Type II and type III saponins | 289 [C19H29O2]−, | ||
| Type IV saponins | 271 [C19H27O]−, 253 [C19H25]−, | ||
| Furostan saponins | Type V saponins | 269 [C19H25O]−, 251 [C19H23]− | |
| Flavonoids | Mangiferin-type flavonoids | 90 (C3H6O3), | |
| Chalcone-type flavonoids | 119 [C8H7O]− or 146 [C9H6O2]− | ||
| Flavanones | 119 [C8H7O]−, | ||
| Homoisoflavonoid | 133 [C9H9O]− | ||
| Icariin-type flavonoids | 367 [C21H19O6]− | 162 (C6H10O5), 132 (C5H8O4) | |
| Phenylpropanoids | coumarins | 107 [C7H7O]−, | |
| Benzophenones | 94 (C6H6O) | ||
| Alkaloids | Amide alkaloids | 119 (C8H7O) |
Figure 1Base peak ion (BPI) chromatograms of substances in the extract of the Rhizoma Anemarrhenae herb, under negative ion mode.
Identification of the chemical constituents of Rhizoma Anemarrhenae extract by using UPLC-Q-TOF/MS in negative ion mode.
| RT | Formula | [M-H]− | Experimental | ppm | Fragment ions | Chemical name | Chemical types | Ref | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2.72 | C25H28O16 | 583.1299 | 583.1299 | 0.00 | 583 [M-H]−, | Neomangiferin | Mangiferin-type flavonoids | [ |
| 2 | 3.27 | C19H18O11 | 421.0771 | 421.0759 | 2.85 | 421 [M-H]−, | Mangiferin | Mangiferin-type flavonoids | [ |
| 3 | 3.32 | C19H18O11 | 421.0771 | 421.0764 | 1.66 | 421 [M-H]−, | Isomangiferin | Mangiferin-type flavonoids | [ |
| 4 | 4.48 | C13H10O5 | 245.0450 | 245.0454 | 1.63 | 245 [M-H]−, | Iriflophenone | Benzophenones | [ |
| 5 | 4.74 | C45H76O20 | 935.4852 | 935.4823 | 3.10 | 917 [M-H-H2O]−, | Timosaponin E1 | Furostanol glycosides | [ |
| 6 | 4.79 | C45H76O20 | 935.4852 | 935.4827 | 2.67 | 935 [M-H]−, | Timosaponin E | Furostanol glycosides | [ |
| 7 | 4.85 | C45H76O20 | 935.4852 | 935.4836 | 1.71 | 935 [M-H]−, | Timosaponin N | Furostanol glycosides | [ |
| 8 | 5.09 | C56H94O29 | 1229.5803 | 1229.5806 | 0.24 | 1211 [M-H-H2O]−, | Purpureagitoside | Furostanol glycosides | [ |
| 9 | 6.32 | C17H17NO3 | 282.1130 | 282.1132 | 0.71 | 282 [M-H]−, | Coumaroyltyramine | Amide alkaloids | [ |
| 10 | 6.86 | C18H19NO4 | 312.1236 | 312.1237 | 0.32 | 312 [M-H]−, | N-trans-feruloyltyrami-ne or N-cis-feruloyltyramine | Amide alkaloids | [ |
| 11 | 7.20 | C45H74O19 | 917.4746 | 917.4751 | 0.54 | 755 [M-H-C6H10O5]−, | Timosaponin D | Furostanol glycosides | [ |
| 12 | 7.49 | C14H12O5 | 259.0607 | 259.0630 | 8.88 | 259 [M-H]−, | 2,6,4′-Trihydroxy-4-methoxyBenzophenone | Benzophenones | [ |
| 13 | 8.12 | C56H92O28 | 1211.5697 | 1211.5642 | 4.54 | 1211 [M-H]−, | Timosaponin H1 | Furostanol glycosides | [ |
| 14 | 8.26 | C56H94O28 | 1213.5854 | 1213.5803 | 4.20 | 1213 [M-H]−, | Timosaponin I1/D1 | Furostanol glycosides | [ |
| 15 | 8.48 | C45H76O19 | 919.4903 | 919.4882 | 2.28 | 919 [M-H]−, | Timosaponin B II or Timosaponin L or (25S)-Officinalisnin-I | Furostanol glycosides | [ |
| 16 | 9.60 | C39H64O15 | 771.4167 | 771.4174 | 0.91 | 771 [M-H]−, | Timosaponin F (C39) | Spirostanol glycosides | [ |
| 17 | 10.01 | C45H74O18 | 901.4797 | 901.4773 | 2.66 | 901 [M-H]−, | Xilingsaponin B | Spirostanol glycosides | [ |
| 18 | 10.14 | C45H74O18 | 901.4797 | 901.4768 | 3.22 | 739 [M-H-C6H10O5]−, | Timosaponin B III | Furostanol glycosides | [ |
| 19 | 10.23 | C45H74O18 | 901.4797 | 901.4807 | 1.11 | 739 [M-H-C6H10O5]−, | Macrostemonoside F or Timosaponin C | Furostanol glycosides | [ |
| 20 | 10.28 | C51H84O23 | 1063.5325 | 1063.5352 | 2.54 | 1063 [M-H]−, | Timosaponin B IV (C51) | Furostanol glycosides | [ |
| 21 | 10.60 | C45H74O18 | 901.4797 | 901.4824 | 3.00 | 739 [M-H-C6H10O5]−, | Macrostemonoside F or Timosaponin C | Furostanol glycosides | [ |
| 22 | 10.69 | C15H12O4 | 255.0658 | 255.0666 | 3.14 | 255 [M-H]−, | 2′,4′,4-Trihydroxychalcone | Chalcone-type flavonoids | [ |
| 23 | 10.73 | C17H16O3 | 267.1021 | 267.1036 | 5.62 | 267 [M-H]−, | Oxy- hinokiresinol | Coumarins | [ |
| 24 | 11.00 | C16H14O5 | 285.0763 | 285.0777 | 4.91 | 285 [M-H]−, | (2S)-7,4′-Dihydroxy-5-methoxyflavone | Flavanones | [ |
| 25 | 11.23 | C16H16O5 | 287.0920 | 287.0931 | 3.83 | 287 [M-H]−, | 2′-O-Methylphloretin | Chalcone-type flavonoids | [ |
| 26 | 11.38 | C39H64O14 | 755.4218 | 755.4218 | 0.00 | 755 [M-H]−, | Timosaponin A II or Timosaponin G (C39) or | Spirostanol glycosides | [ |
| 27 | 12.25 | C16H18O3 | 257.1178 | 257.1190 | 4.67 | 257 [M-H]−, | Broussonin A or Broussonin B | Coumarins | [ |
| 28 | 13.16 | C17H16O2 | 251.1072 | 251.1075 | 1.19 | 251 [M-H]−, | Hinokiresinol | Coumarins | [ |
| 29 | 16.17 | C39H64O13 | 739.4269 | 739.4252 | 2.30 | 739 [M-H]−, | Timosaponin AIII | Spirostanol glycosides | [ |
| 30 | 16.25 | C39H64O13 | 739.4269 | 739.4280 | 1.49 | 739 [M-H]−, | Timosaponin AIV | Spirostanol glycosides | [ |
| 31 | 16.38 | C39H64O13 | 739.4269 | 739.4286 | 2.30 | 739 [M-H]−, | Smilageninoside | Spirostanol glycosides | [ |
| 32 | 16.73 | C18H18O2 | 265.1229 | 265.1235 | 2.26 | 265 [M-H]−, | Monomethyl-cis-hinokiresinol | Coumarins | [ |
Figure 2The fragmentation patterns of furostan saponins (type III), taking purpureagitoside as the example: the ion at m/z 1229 was the molecular ion [M-H]−, the fragmentation at m/z 1211 indicated a loss of 18 Da (H2O) on the basis of the parent ion, the fragment ions m/z 431 displayed the loss of sugar group, the fragment ion (m/z 289) was formed by the cleavage of the E-ring on the basis of the fragment ion (m/z 431), and the fragment ions (m/z 271 and 253) were obtained by a loss of 18 Da (H2O) or 2 × 18 Da (H2O) on the basis of the fragment ion (m/z 289).
Figure 3The fragmentation pathways of spirostanol saponins, taking purpureagitoside as the example: the ion at m/z 739 was the molecular ion [M-H]−, the ion at m/z 577 [M-H-C6H10O5]− was produced by the loss of a hexose unit (Glc, 162 Da), the fragment ion at m/z 415 [M-H-2C6H10O5]− could be explained by ejecting a pentose unit (Gal, 162 Da) from the ion at m/z 577, the fragment ion at m/z 273 was formed by the cleavage of the E-ring, and the fragmentation of m/z 255 was obtained by the fragmentation m/z 273 to lose a water molecule.
Figure 4The specific fragmentation process of mangiferin flavonoids, take neomangiferin as an example: The fragment ion at m/z 583 [M-H]− was a molecular ion, m/z 421 displayed a loss of 162 Da (C6H10O5) based on the parent ion, the fragment ion at m/z 331 [M-H-C6H10O5-C3H6O3]− conformed to the rule of C-glycosides loss 90 Da (C3H6O3) and m/z 301 [M-H-C6H10O5-C4H8O4]− followed the rules of C-glycosides loss 120 Da (C4H8O4) from sugar molecules through 0,3X/0,2X cleavage.
Figure 5The specific fragmentation process of chalcone flavonoids, take 2′,4′,4-trihydroxychalcone as an example: the fragment ion of m/z 255 [M-H]− is molecular ion and the fragment ions at m/z 135 and 119 resulting from separation of A and B rings.
Figure 6A fragmentation pathway of lignans formed in MS, take hinokiresinol as an example: the fragment ion of m/z 251 [M-H]− was molecular ion and the fragment ion at m/z 107 was produced as result of benzyl cleavage. The fragment ions m/z indicated a loss of water molecular based on the fragment ion at m/z 107.
Figure 7A fragmentation pathway of benzophenone formed in MS, take 2,6,4′-trihydroxy-4-methoxybenzophenone as an example: m/z 259 [M-H]− is parent ion, the fragment ion at m/z 165 indicated a loss of 94 Da (C6H6O) based on the parent ion, and the fragment ion at m/z 121 indicated a loss of one CO2 molecule based on the fragment at m/z 165.